Advisors Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$261K	Buy	4,724 +3	+0.1%	+$166	﹤0.01%	1071
2025 Q1	$228K	Buy	4,721 +2,123	+82%	+$103K	﹤0.01%	1086
2024 Q4	$100K	Buy	+2,598	New	+$100K	﹤0.01%	1223